ROLE OF CHLORAMBUCIL IN COMBINATION OR NOT WITH ANTI‐CD20 AS FRONTLINE THERAPY IN CHRONIC LYMPHOCYTIC LEUKEMIA IN "REAL LIFE" by Santamaria Lopez, A., Perez Persona, E., Cuevas Palomares, L., Oiartzabal Ormategui, I., Unamunzaga Cilaurren, A., Parra Salinas, I., Robles de Castro, D., De Miguel Sánchez, C., Gabilondo Jalón, M., Pisón Herrero, C., Mendez Navarro, G., Vega Gonzalez de Viñaspe, A., Guinea de Castro, J.

Get full text

PB2122 VELCADITO. A PHASE II TRIAL WITH LOW DOSES OF BORTEZOMIB PLUS MELPHALAN AND PREDNISONE FOR ELDERLY PATIENTS (>75Y) WITH NEWLY DIAGNOSED MULTIPLE MYELOMA by Persona, E. Pérez, Ormategui, I. Oiartzabal, Angulo, R. Diez, Cilaurren, A. Unamunzaga, Salinas, I. M. Parra, Lopez, A. Santamaría, Palomares, L. Cuevas, Robles de Castro, D., Miguel Sánchez, C., Jalón, M. Gabilondo, Herrero, C. Pisón, Navarro, G. A. Mendez, Vega González de Viñaspre, A., Guinea de Castro, J. M.

Request full text

PS1404 RELATIONSHIP BETWEEN COMORBIDITY AND ELIGIBILITY CRITERIA FOR CLINICAL TRIALS IN MULTIPLE MYELOMA. A CRITICAL APPRAISAL by Persona, E. Pérez, Ormategui, I. Oiartzabal, Viñaspre, A. Vega González, Cilaurren, A. Unamunzaga, López, A. Santamaría, Castro, D. Robles, Miguel Sánchez, C., Palomares, L. Cuevas, Jalón, M. Gabilondo, Navarro, G.A. Mendez, Salinas, I.M. Parra, Herrero, C. Pisón, Castro, J.M. Guinea

Request full text